Literature DB >> 8683472

Behaviour of raphe cells projecting to the dorsomedial medulla during carbachol-induced atonia in the cat.

G Woch1, R O Davies, A I Pack, L Kubin.   

Abstract

1. The activity of most brainstem serotonergic cells is suppressed during sleep, particularly the rapid eye movement (REM) phase. Thus, they may play a major role in state-dependent changes in CNS functioning. Our main goal was to search for medullary raphe cells having axonal branches in the region of the hypoglossal (XII) motor nucleus and assess their behaviour during the atonia produced by microinjections of a cholinergic agonist, carbachol, into the dorsal pontine tegmentum. In chronic animals, such microinjections evoke a desynchronized sleep-like state similar to natural REM sleep; in decerebrate animals, they produce eye movements and a motor suppression similar to the postural atonia of REM sleep. 2. In decerebrate, paralysed, vagotomized and artificially ventilated cats, we recorded extracellularly from medullary raphe cells antidromically activated from the XII nucleus region. Forty-five cells recorded in the raphe obscurus and pallidus nuclei were antidromically activated with latencies characteristic of non-myelinated fibres (4.4-42.0 ms). For thirty-three of the forty-five cells, we found one or more axonal branches within or just below the XII nucleus. The remaining twelve cells, in addition to the XII nucleus, had axonal ramifications in the medial nucleus of the solitary tract (NTS) and/or the dorsal motor nucleus of the vagus (DMV). 3. A subset of fourteen spontaneously active cells with identified axonal projections were held long enough to be recorded during the carbachol-induced atonia, and eight of these also during the subsequent recovery and a systemic administration of the serotonergic 1A receptor agonist (+/-)8-hydroxy-2-(di-N-propylamino)tetrealin hydrobromide (8-OH-DPAT). All but one were suppressed during the atonia in parallel to the suppression of XII, phrenic and postural nerve activities (firing rate, 1.3 +/- 0.7 Hz before and 0.1 +/- 0.2 Hz after carbachol (means +/- S.D.)). Following the recovery from the atonia, the firing rates of the eight cells increased to the pre-carbachol level (1.6 +/- 1.0 Hz). Subsequently, all were silenced by 8-OH-DPAT. 4. These cells fulfil most physiological criteria for serotonergic cells and have the potential to modulate, in a state-dependent manner, activities in the motor XII nucleus, visceral sensory NTS, and DMV. The decrements in serotonergic neuronal activity that occur during the carbachol-induced atonia suggest that a similar withdrawal of serotonergic input may occur during REM sleep and contribute to the characteristic reductions in upper airway motor tone.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8683472      PMCID: PMC1158711          DOI: 10.1113/jphysiol.1996.sp021182

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  36 in total

1.  Cholinergic stimulation of the pons depresses respiration in decerebrate cats.

Authors:  H Kimura; L Kubin; R O Davies; A I Pack
Journal:  J Appl Physiol (1985)       Date:  1990-12

2.  Nuclei of origin of monoaminergic, peptidergic, and cholinergic afferents to the cat trigeminal motor nucleus: a double-labeling study with cholera-toxin as a retrograde tracer.

Authors:  P Fort; P H Luppi; K Sakai; D Salvert; M Jouvet
Journal:  J Comp Neurol       Date:  1990-11-08       Impact factor: 3.215

Review 3.  Structure and function of the brain serotonin system.

Authors:  B L Jacobs; E C Azmitia
Journal:  Physiol Rev       Date:  1992-01       Impact factor: 37.312

Review 4.  Serotonin- and substance P-containing projections to the nucleus tractus solitarii of the rat.

Authors:  K B Thor; C J Helke
Journal:  J Comp Neurol       Date:  1987-11-08       Impact factor: 3.215

5.  Identification of serotonergic and sympathetic neurons in medullary raphe nuclei.

Authors:  R B McCall; M E Clement
Journal:  Brain Res       Date:  1989-01-16       Impact factor: 3.252

6.  Mapping of cholinoceptive brainstem structures responsible for the generation of paradoxical sleep in the cat.

Authors:  G Vanni-Mercier; K Sakai; J S Lin; M Jouvet
Journal:  Arch Ital Biol       Date:  1989-06       Impact factor: 1.000

7.  Motoneuron properties during motor inhibition produced by microinjection of carbachol into the pontine reticular formation of the decerebrate cat.

Authors:  F R Morales; J K Engelhardt; P J Soja; A E Pereda; M H Chase
Journal:  J Neurophysiol       Date:  1987-04       Impact factor: 2.714

8.  Central serotonergic projections to the nucleus tractus solitarii: evidence from a double labeling study in the rat.

Authors:  N Schaffar; J P Kessler; O Bosler; A Jean
Journal:  Neuroscience       Date:  1988-09       Impact factor: 3.590

9.  Enhancement of acetylcholine release during paradoxical sleep in the dorsal tegmental field of the cat brain stem.

Authors:  T Kodama; Y Takahashi; Y Honda
Journal:  Neurosci Lett       Date:  1990-07-13       Impact factor: 3.046

10.  Cardiovascular and muscle tone changes produced by microinjection of cholinergic and glutamatergic agonists in dorsolateral pons and medial medulla.

Authors:  Y Y Lai; J M Siegel
Journal:  Brain Res       Date:  1990-04-23       Impact factor: 3.610

View more
  18 in total

1.  Changes in cat medullary neurone firing rates and synchrony following induction of respiratory long-term facilitation.

Authors:  K F Morris; R Shannon; B G Lindsey
Journal:  J Physiol       Date:  2001-04-15       Impact factor: 5.182

2.  GABAA receptor antagonism at the hypoglossal motor nucleus increases genioglossus muscle activity in NREM but not REM sleep.

Authors:  Janna L Morrison; Sandeep Sood; Hattie Liu; Eileen Park; Philip Nolan; Richard L Horner
Journal:  J Physiol       Date:  2003-02-28       Impact factor: 5.182

Review 3.  Brainstem mechanisms of paradoxical (REM) sleep generation.

Authors:  Pierre-Hervé Luppi; Olivier Clement; Emilie Sapin; Christelle Peyron; Damien Gervasoni; Lucienne Léger; Patrice Fort
Journal:  Pflugers Arch       Date:  2011-11-15       Impact factor: 3.657

4.  REM sleep-like atonia of hypoglossal (XII) motoneurons is caused by loss of noradrenergic and serotonergic inputs.

Authors:  Victor B Fenik; Richard O Davies; Leszek Kubin
Journal:  Am J Respir Crit Care Med       Date:  2005-08-11       Impact factor: 21.405

5.  Disinhibition of perifornical hypothalamic neurones activates noradrenergic neurones and blocks pontine carbachol-induced REM sleep-like episodes in rats.

Authors:  Jackie W Lu; Victor B Fenik; Jennifer L Branconi; Graziella L Mann; Irma Rukhadze; Leszek Kubin
Journal:  J Physiol       Date:  2007-05-10       Impact factor: 5.182

6.  Prenatal nicotine exposure increases apnoea and reduces nicotinic potentiation of hypoglossal inspiratory output in mice.

Authors:  Dean M Robinson; Karen C Peebles; Henry Kwok; Brandon M Adams; Lan-Ling Clarke; Gerald A Woollard; Gregory D Funk
Journal:  J Physiol       Date:  2002-02-01       Impact factor: 5.182

7.  Microdialysis perfusion of 5-HT into hypoglossal motor nucleus differentially modulates genioglossus activity across natural sleep-wake states in rats.

Authors:  A Jelev; S Sood; H Liu; P Nolan; R L Horner
Journal:  J Physiol       Date:  2001-04-15       Impact factor: 5.182

Review 8.  Synaptic control of motoneuronal excitability.

Authors:  J C Rekling; G D Funk; D A Bayliss; X W Dong; J L Feldman
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

9.  The modulation by 5-HT of glutamatergic inputs from the raphe pallidus to rat hypoglossal motoneurones, in vitro.

Authors:  Vitali A Bouryi; David I Lewis
Journal:  J Physiol       Date:  2003-10-10       Impact factor: 5.182

10.  Role of inhibitory amino acids in control of hypoglossal motor outflow to genioglossus muscle in naturally sleeping rats.

Authors:  Janna L Morrison; Sandeep Sood; Hattie Liu; Eileen Park; Xia Liu; Philip Nolan; Richard L Horner
Journal:  J Physiol       Date:  2003-08-22       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.